In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.READ MORE
You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.READ MORE
As a neuroscientist researching how food and drink affect brain function, let me explain how drinking alcohol can trigger hangxiety the next day.READ MORE
In this interview we speak to Maastricht University's Professor Johannes Ramaekers, who recently collaborated with the UK-based Beckley foundation to examine the effects of microdosing LSD. In this interview, we discuss how LSD affects our mood, how mushrooms could boost creativity and why a Mexican toad has been an important part of psychedelic research.
Fred Barrett is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University in Baltimore. In this interview, we discuss his work with the active component of magic mushrooms, psilocybin. Fred explains how this compound affects the brain, its potential to combat visceral pain, and its links to so-called mystical experiences.
A new study conducted by researchers at Paris’s Sorbonne University, alongside colleagues from the US and Australia has now suggested that magnetic stimulation may be able to help the brain repair itself. What’s more, the team has gone one step further by identifying a molecule that they suggest may mediate this healing effect.READ MORE
Scientists can now use super-resolution microscopy to directly observe living subcellular structures and activities. In this piece, we explore the basics of three popular super-resolution techniques.
Professor David Nutt has never been afraid to stick his head above the parapet on the topic of drugs. His repeated calling-out of the failures of contemporary drug policy has seen him butt heads with academics and politicians alike. In this interview with Professor Nutt, we discuss pot, policy and the potential of psilocybin.READ MORE
In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.READ MORE